Vraylar (Cariprazine) Approved For Schizophrenia & Bipolar Disorder
Vraylar (Cariprazine) was approved by the FDA on September 17, 2015 for the treatment of schizophrenia and mania associated with bipolar disorder. In clinical trials, the drug was referenced…
Read article